What is the ‘cadaver skin jab’?
The nickname refers to Elravie Re2O, a skin booster injection launched in November 2024 by South Korean company L&C Bio and distributed by Humedix. According to the distributor, it contains human acellular dermal matrix, a material made from processed skin tissue from deceased donors, sourced through tissue banks in the United States, with the cells removed.
The company says the product improves skin condition by supplying structural proteins such as collagen and elastin, describing it as a form of structural replenishment for aged or damaged skin rather than a booster that offers only temporary stimulation. Its unusual origin, and the striking nickname, have helped it spread rapidly across social media.
Why it is under scrutiny in Hong Kong
Hong Kong authorities have moved quickly against the unregistered product:
- The Department of Health, in a joint operation with police, seized 20 vials of Elravie Re2O from four beauty service premises in Mong Kok and Tsim Sha Tsui over the past week.
- A 38-year-old woman was arrested on suspicion of unlawful commercial dealing in human organs and unlawful possession of Part 1 poisons and unregistered pharmaceutical products.















